Skip to navigation Skip to Content

Search

Menu
Search Marshfield Clinic Health System
Join a world-class health system. Find jobs

Marshfield Clinic Health System is first to use new ovarian cancer surgery technology

​​June 21, 2024

MARSHFIELD – Marshfield Clinic Health System recently became the first healthcare system in the world to use the novel imaging agent, CYTALUX, in combination with the Stryker 1788 imaging platform for ovarian cancer surgery since CYTALUX received U.S. Food and Drug Administration approval. The new technology, CYTALUX, aids in ovarian cancer cytoreduction, or surgery to remove the tumor and any nearby tissues the cancer spread to.

​This technology marks a significant milestone in the Health System's commitment to advancing patient care.

“We're the world's pioneer in bringing this revolutionary advancement into standard practice for the benefit of our patients," said Dr. Rohit Sharma, Marshfield Clinic Health System surgical oncologist and surgeon in the CYTALUX operating team. “CYTALUX will elevate our standard of surgical cytoreduction for ovarian cancer."

CYTALUX is the only FDA approved fluorescent imaging technology to light up lung cancer during surgery — enhancing surgeons' ability to visualize cancer in real time. The technology provides significant benefits to the surgical team and oncology patients, including:

  • Instant, real-time visualization of cancer during surgery, which enables more precise and targeted removal of cancerous tissues.
  • Improved accuracy during surgical procedures, enabling the detection of more cancer for removal.
  • Minimal impact on surrounding healthy tissues, ensuring the surgery is as focused and non-invasive as possible.
  • The ability to be used in various surgical settings and is also indicated for use in lung cancer.

This milestone was achieved through collaboration among the Health System's surgery, anesthesia, nursing and nursing operating room teams, pharmacy, and revenue cycle leadership teams.

“We are excite d about the positive impact this technology will have on patient outcomes and on our reputation as leaders and innovators in the health care field," said Dr. Adedayo Onitilo, medical director, Cancer Care & Research and oncology service line medical director. “We now stand as a forerunner in cancer care in the nation."

​​

 Media Relations

John Gardner
Marshfield Clinic Health System Director of Communications
715 221-8659
gardner.john
@marshfieldclinic.org

Jeff Starck
Senior Media Relations Specialist - Marshfield, Eau Claire, Ladysmith, Minocqua, Neillsville, Park Falls, & Rice Lake
715 389-4978
starck.jeffrey
@marshfieldclinic.org

Dan Baulch
Senior Communications
Specialist -
Beaver Dam
920 887-4152
baulch.dan
@marshfieldclinic.org

Jim Korth
Communications Specialist – Wausau/Weston
715-679-5455
korth.james
@marshfieldclinic.org

Joe Rizzo
Director of Public Relations and Business Development –
Marshfield Medical
Center-Dickinson
906-776-5671
Joe.Rizzo@dchs.org